Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Use of Release Liners in Transdermal Patches Production

Posted on By

SOP for Use of Release Liners in Transdermal Patches Production

Standard Operating Procedure for Use of Release Liners in Transdermal Patches Production

1) Purpose

The purpose of this SOP is to define procedures for the selection, handling, and application of release liners used in the production of transdermal patches.

2) Scope

This SOP applies to the use of release liners during all stages of transdermal patch production, including coating, lamination, and final packaging, within the facility.

3) Responsibilities

The Production Department is responsible for implementing and overseeing the use of release liners as per this SOP. Quality Control (QC) personnel may conduct checks and inspections as required.

See also  SOP for Temperature Cycling Testing for Transdermal Patches

4) Procedure

4.1 Release Liner Selection

  • 4.1.1 Select release liners based on product specifications, including release characteristics, thickness, and compatibility with adhesive and backing materials.
  • 4.1.2 Verify that selected liners meet regulatory requirements and are sourced from approved suppliers.

4.2 Handling and Preparation

  • 4.2.1 Handle release liners carefully to avoid wrinkles, tears, or contamination that could affect their release properties.
  • 4.2.2 Ensure release liners are stored in controlled conditions (e.g., temperature and humidity) to maintain their integrity and performance.

4.3 Application and Integration

  • 4.3.1 Prepare release liners for integration into patch production processes, ensuring compatibility with adhesive and backing materials.
  • 4.3.2 Apply release liners according to validated procedures and batch-specific
instructions to facilitate efficient patch manufacturing.

4.4 Quality Control Checks

  • 4.4.1 Inspect release liners for defects, such as air bubbles, creases, or uneven application, that could compromise their function.
  • 4.4.2 Conduct release force testing to measure the ease and consistency of liner removal from adhesive-coated patches.

4.5 Documentation and Reporting

  • 4.5.1 Document all activities related to the use of release liners in batch records or production logs, including liner details, application parameters, and quality control results.
  • 4.5.2 Record any deviations from standard procedures and document corrective actions taken to address issues promptly.

5) Abbreviations, if any

SOP: Standard Operating Procedure
QC: Quality Control

6) Documents, if any

Release Liner Specifications
Batch Records
Supplier Certificates

7) Reference, if any

ISO 12625: Release liners for pressure-sensitive adhesive-coated films
ISO 22487: Packaging – Flexible packaging and wrapping materials

8) SOP Version

Version 1.0

See also  SOP for Validation of Cleaning Procedures in Transdermal Patches Production
Transdermal Patches Tags:Adhesion Testing Protocol, Analytical Method Development SOP, Assay of Active Ingredient SOP, Contamination Prevention SOP, Documentation SOP, Equipment calibration SOP, Equipment Cleaning SOP, Final Product Inspection SOP, Formulation development SOP, Homogeneity Testing SOP, In-process Testing SOP, Microbial Testing SOP, Personnel Training SOP, Process Optimization SOP, Process Validation SOP, Quality Control Transdermal Patches, Raw Material Inspection SOP, Release Rate Testing SOP, Sample Collection SOP, Sterility Maintenance SOP, Storage Conditions Transdermal Patches, Thickness Testing Procedure, Transdermal Patch Manufacturing SOP, Transdermal Patch Stability Testing, Waste Handling SOP

Post navigation

Previous Post: SOP for Distribution and Transport Conditions for Aerosols
Next Post: SOP for Pharmacovigilance Regulatory Submission

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version